MSH2 and endometrial cancer: MMR deficiency in endometrial cancer may be best assessed using immunohistochemical (IHC) staining for the four major DNA mismatch repair proteins (MLH1, MSH2, MSH6 and PMS2), which appears to outperform the classical microsatellite instability testing [53].